Royal Bank of Canada’s iKang Healthcare Group, Inc. KANG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-17
Closed 7394
2018
Q4
$0 Sell
17
-584
-97% -$10.4K ﹤0.01% 7457
2018
Q3
$11K Buy
601
+253
+73% +$4.87K ﹤0.01% 5970
2018
Q2
$7K Buy
+348
New +$7.02K ﹤0.01% 5966
2018
Q1
Sell
-6
Closed 7113
2017
Q4
$0 Sell
6
-8
-57% -$116 ﹤0.01% 7188
2017
Q3
$0 Buy
+14
New +$187 ﹤0.01% 7189
2017
Q1
Sell
-2,000
Closed -$35K 6955
2016
Q4
$35K Buy
+2,000
New +$33.8K ﹤0.01% 5470
2016
Q2
Sell
-16
Closed 6652
2016
Q1
$0 Sell
16
-3,479
-100% -$72.5K ﹤0.01% 6845
2015
Q4
$71K Buy
3,495
+3,490
+69,800% +$60.2K ﹤0.01% 5133
2015
Q3
$0 Buy
+5
New +$81 ﹤0.01% 6880
2015
Q2
Sell
-39
Closed -$1K 6815
2015
Q1
$1K Buy
+39
New +$651 ﹤0.01% 6024

Royal Bank of Canada's KANG Position: Q1 2019 in Review

Royal Bank of Canada sold out of iKang Healthcare Group, Inc. (KANG) in Q1 2019, closing a stake of 17 shares.

Royal Bank of Canada first reported a position in KANG in Q1 2015 and held it in 10 quarters. The position peaked at $71K in Q4 2015. 0 funds tracked by Wall St. Rank hold KANG as of Q1 2019.

  • Royal Bank of Canada reported no remaining iKang Healthcare Group, Inc. position as of Q1 2019 after selling out during the quarter.
  • Royal Bank of Canada sold 17 iKang Healthcare Group, Inc. shares in Q1 2019.
  • Royal Bank of Canada first reported a position in iKang Healthcare Group, Inc. in Q1 2015 and held it in 10 quarters.
  • Royal Bank of Canada's iKang Healthcare Group, Inc. position peaked at $71K in Q4 2015.
  • 0 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q1 2019.

Based on Royal Bank of Canada's 13F filing for Q1 2019, filed 15 May 2019.